Strata Skin Sciences ROA 2010-2023 | SSKN

Current and historical return on assets (ROA) values for Strata Skin Sciences (SSKN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Strata Skin Sciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2023-12-31 $-0.01B $0.04B -22.80%
2023-09-30 $-0.01B $0.05B -13.79%
2023-06-30 $-0.01B $0.06B -13.40%
2023-03-31 $-0.01B $0.05B -11.54%
2022-12-31 $-0.01B $0.05B -11.21%
2022-09-30 $-0.01B $0.05B -13.40%
2022-06-30 $-0.01B $0.05B -13.79%
2022-03-31 $-0.00B $0.06B -8.25%
2021-12-31 $-0.00B $0.05B -6.49%
2021-09-30 $-0.00B $0.05B -4.32%
2021-06-30 $-0.00B $0.05B -4.32%
2021-03-31 $-0.01B $0.05B -10.75%
2020-12-31 $-0.00B $0.05B -8.60%
2020-09-30 $-0.01B $0.05B -10.75%
2020-06-30 $-0.01B $0.05B -10.70%
2020-03-31 $-0.00B $0.05B -8.47%
2019-12-31 $-0.00B $0.05B -8.38%
2019-09-30 $-0.00B $0.05B -6.25%
2019-06-30 $-0.00B $0.05B -6.32%
2019-03-31 $-0.00B $0.05B -6.38%
2018-12-31 $-0.00B $0.05B -9.04%
2018-09-30 $-0.01B $0.05B -19.05%
2018-06-30 $-0.02B $0.05B -51.85%
2018-03-31 $-0.02B $0.04B -52.83%
2017-12-31 $-0.02B $0.04B -50.91%
2017-09-30 $-0.02B $0.04B -42.60%
2017-06-30 $-0.01B $0.04B -13.95%
2017-03-31 $-0.01B $0.04B -11.56%
2016-12-31 $-0.00B $0.04B -8.99%
2016-09-30 $-0.00B $0.04B -8.65%
2016-06-30 $-0.01B $0.04B -28.87%
2016-03-31 $-0.02B $0.05B -43.14%
2015-12-31 $-0.03B $0.05B -65.12%
2015-09-30 $-0.03B $0.05B -92.96%
2015-06-30 $-0.02B $0.05B -80.70%
2015-03-31 $-0.01B $0.02B -77.78%
2014-12-31 $-0.02B $0.02B -82.19%
2014-09-30 $-0.01B $0.02B -83.58%
2014-06-30 $-0.02B $0.01B -135.71%
2014-03-31 $-0.03B $0.02B -152.11%
2013-12-31 $-0.03B $0.01B -120.93%
2013-09-30 $-0.03B $0.01B -121.35%
2013-06-30 $-0.03B $0.03B -104.17%
2013-03-31 $-0.02B $0.03B -101.10%
2012-12-31 $-0.02B $0.02B -103.53%
2012-09-30 $-0.02B $0.02B -84.85%
2012-06-30 $-0.02B $0.02B -88.89%
2012-03-31 $-0.02B $0.03B -87.13%
2011-12-31 $-0.02B $0.03B -80.77%
2011-09-30 $-0.02B $0.02B -78.50%
2011-06-30 $-0.02B $0.02B -63.49%
2011-03-31 $-0.02B $0.03B -61.54%
2010-12-31 $-0.02B $0.03B -59.70%
2010-09-30 $-0.02B $0.04B -63.64%
2010-06-30 $-0.02B $0.03B -70.59%
2010-03-31 $-0.02B $0.03B -80.00%
2009-12-31 $-0.02B $0.03B -95.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.020B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.573B 22.01
Inspire Medical Systems (INSP) United States $7.095B 0.00
IRhythm Technologies (IRTC) United States $3.623B 0.00
Axonics (AXNX) United States $3.399B 0.00
10x Genomics (TXG) United States $3.279B 0.00
Enovis (ENOV) United States $3.080B 23.40
Azenta (AZTA) United States $2.905B 236.77
Olink Holding AB (publ) (OLK) Sweden $2.789B 0.00
Hims & Hers Health (HIMS) United States $2.644B 0.00
Privia Health (PRVA) United States $2.156B 95.63
Schrodinger (SDGR) United States $1.738B 0.00
Omnicell (OMCL) United States $1.260B 30.82
Phreesia (PHR) United States $1.237B 0.00
Definitive Healthcare (DH) United States $0.854B 0.00
Standard BioTools (LAB) United States $0.702B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Talkspace (TALK) United States $0.519B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Clover Health Investments (CLOV) United States $0.322B 0.00
Pulmonx (LUNG) United States $0.290B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
P3 Health Partners (PIII) United States $0.158B 0.00
American Well (AMWL) United States $0.154B 0.00
Butterfly Network (BFLY) United States $0.147B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.132B 0.00
TruBridge (TBRG) United States $0.116B 4.95
111 (YI) China $0.088B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.014B 0.00
Biotricity (BTCY) United States $0.013B 0.00
Centogene (CNTG) Germany $0.012B 0.00
Transgenomic (PRPO) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00